Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma (Q28370901)
scientific article
Language:
Current Data About Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma
(P31) (Q13442814)

(P304) 137-45

(P407) (Q1860)

(P433) 2

(P478) 74

(P577) +1999-02-00T00:00:00Z

(P921) (Q2620873)

(P1433) (Q6538184)

(P1476) "Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma" (language: en)

(P2093) J C Buckner
(P1545) 1

M G Malkin
(P1545) 2

E Reed
(P1545) 3

T L Cascino
(P1545) 4

J M Reid
(P1545) 5

M M Ames
(P1545) 6

W P Tong
(P1545) 7

S Lim
(P1545) 8

W D Figg
(P1545) 9

other details
description scientific article

External Links
(P356) 10.4065/74.2.137
(P698) 10069350
(P5875) 13222149